Literature DB >> 30707048

Increased Aqueous Humor Symmetric Dimethylarginine Level in Patients with Primary Open Angle Glaucoma.

Penpe Gül Firat1, Ersan Ersin Demirel2, Soner Demirel1, Seyhan Dikci1, Yusuf Turkoz3, Fatma Ozyalın3.   

Abstract

Purpose: To evaluate the asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and L-arginine (L-Arg) levels both in plasma and aqueous humor of primary open angle glaucoma (POAG) patients and matched controls. Patients and
Methods: 25 primary open angle glaucoma patients and 42 control cases with senile cataract were included in the study. Plasma and aqueous humor ADMA, SDMA and L-Arg levels of the participants were measured by using liquid chromatography-tandem mass spectrometry.
Results: A significant increase in aqueous humor SDMA level was detected in POAG patients compared with controls (p = 0.0115). No significant difference was detected in plasma and aqueous humor ADMA, L-Arg levels.
Conclusion: The aqueous humor levels of SDMA are found to be associated with POAG. The result of this current study supports the role of nitric oxide pathway in glaucoma.

Entities:  

Keywords:  Glaucoma; L-arginine; asymmetric dimethylarginine; symmetric dimethylarginine

Mesh:

Substances:

Year:  2019        PMID: 30707048     DOI: 10.1080/02713683.2019.1578378

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  2 in total

1.  Elevated dimethylarginine, ATP, cytokines, metabolic remodeling involving tryptophan metabolism and potential microglial inflammation characterize primary open angle glaucoma.

Authors:  Sujith Kumar Pulukool; Sai Krishna Srimadh Bhagavatham; Vishnu Kannan; Piruthivi Sukumar; Rajesh Babu Dandamudi; Shamika Ghaisas; Haripriya Kunchala; Darshan Saieesh; Ashwin Ashok Naik; Ashish Pargaonkar; Anuj Sharma; Venketesh Sivaramakrishnan
Journal:  Sci Rep       Date:  2021-05-07       Impact factor: 4.379

2.  Association Between the Asymmetric Dimethylarginine Levels and Glaucoma Severity: A Cross-Sectional Analysis of the LIGHT Study.

Authors:  Tadanobu Yoshikawa; Kenji Obayashi; Kimie Miyata; Keigo Saeki; Nahoko Ogata
Journal:  Invest Ophthalmol Vis Sci       Date:  2021-04-01       Impact factor: 4.799

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.